Loading...
•
Dec 31, 2025
Pacira Q4 2025 Earnings Report
Pacira reported fourth quarter 2025 revenue growth driven by EXPAREL, with lower profitability and adjusted EBITDA compared to the prior year period.
Key Takeaways
In Q4 2025, Pacira generated total revenues of 196873000 and GAAP net income of 1637000, as higher operating expenses offset revenue growth, while adjusted EBITDA was 38709000.
Total revenues increased 5% year-over-year to 196873000.
EXPAREL sales grew to 155782000, up from 147676000 in Q4 2024.
GAAP net income declined to 1637000 from 16041000 year-over-year.
Adjusted EBITDA was 38709000 compared to 62461000 in Q4 2024.
Revenue by Segment
Forward Guidance
For full year 2026, Pacira expects total revenues between 745000000 and 770000000 and non-GAAP gross margin of 77% to 79%.
Positive Outlook
- EXPAREL net product sales expected between 600000000 and 620000000.
- Total revenue guidance of 745000000 to 770000000.
- Non-GAAP gross margin projected at 77% to 79%.
- Non-GAAP R&D expense expected between 105000000 and 115000000.
- Non-GAAP SG&A expense expected between 320000000 and 340000000.
Challenges Ahead
- GAAP R&D expense expected between 116000000 and 128000000.
- GAAP SG&A expense expected between 359000000 and 386000000.
- Stock-based compensation expected between 54000000 and 62000000.
- Adjusted EBITDA declined year-over-year in Q4 2025.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...